Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The Semaglutide Story: Highlighting The Need To Maintain Patent Protection In Canada

Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic® (type 2 diabetes) and Wegovy® (weight loss), has rapidly become one of the most consequential drugs in modern healthcare.

BC

Brunet & Co

Not All That Bubbles Is Champagne – Considerations For The Protection Of Geographical Indications In Canada

Geographical indications (GIs), such as Champagne, Cognac, and Parmigiano Reggiano, are designations used to identify products whose characteristics, reputation, or quality are fundamentally linked to their geographical origin.

SB

Smart & Biggar

Turning Over A New Leaf? Federal Court Upholds Decision Of Trademarks Opposition Board On Non-distinctive And Confusion Grounds

On July 2, 2025, the Federal Court of Canada (the Court) dismissed an appeal by the University of British Columbia (UBC) of a decision of the Trademarks Opposition Board (the TMOB)...

D

Dentons

Naming Prescription Drugs: Navigating Regulatory And Trademark Challenges

Choosing a "brand name" for prescription drugs in Canada is not just about creativity or marketing appeal – it is a careful balance between legal and regulatory requirements.

ML

McMillan LLP

No Cherry Picking Here: Canadian Cherry Patent Victory In U.S. Agribusiness Intellectual Property Case

F

Fasken

CFIA Reinforces Accuracy In "Product Of Canada" And "Made In Canada" Claims

Canada Healthcare

MT

McCarthy Tétrault LLP

Health Canada To Modernize Biologic Drug Submissions

Canada Healthcare

TL

Torys LLP

Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques

MT

McCarthy Tétrault LLP

Important Changes To The Exception Patient Measure In Quebec

Canada Healthcare

F

Fasken

Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime

MT

McCarthy Tétrault LLP

Patented Medicine Prices Review Board Publishes New Guidelines For PMPRB Staff: Finally, Some Guidance For Patentees

BL

Borden Ladner Gervais LLP

Les nouvelles lignes directrices du CEPMB sont enfin disponibles

Canada Healthcare

FF

Fasken (French)

The Court Grants An Appeal In Favour Of Psychedelic Assisted Psychotherapy – Toth v. Canada, 2025 FCA 119

Canada Healthcare

ML

McMillan LLP

Patents And Prior Art: Federal Court Clarifies Standards For Anticipation And Obviousness

AB

Aird & Berlis LLP

Appointing Someone To Make Health Care Decisions If You Become Unable To

Canada Healthcare

ML

McKercher LLP

Conflit d'intérêts dans l'administration d'une succession : ce que l'affaire Virdi Estate (Re) enseigne aux exécuteurs testamentaires

Canada Litigation

MT

Miller Thomson LLP

Canadian Intellectual Property Office "Next Generation Patents" Update And Status As Of May 13, 2025

SB

Smart & Biggar

Webinar: 2025 Global In-House Counsel Survey Report: Unique Insights Into The Global In-House Counsel Profession

Worldwide Law Practice

IC

In-House Counsel Worldwide

Wagg Motions: Reforms Needed To Stop Delays And Unnecessary Costs When Accessing Criminal Records For Civil Sexual Assault Proceedings

Canada Litigation

LL

Lerners LLP

2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law

In the first half of 2025, the Rx IP Update team reported on a number of developments in Canadian life sciences IP and regulatory law. Below are our top stories.

Canada Healthcare

SB

Smart & Biggar

Important New Procedural Guidelines From The PMPRB

The Patented Medicine Prices Review Board (PMPRB) is a Canadian federal agency that regulates the prices of patented medicines in Canada.

AM

Aird & McBurney LP

Final Guidelines From Canada's PMPRB: The New Era Begins

On June 30, 2025, the PMPRB published final non-binding guidelines (Guidelines) titled Guidelines for PMPRB Staff: Administrative Process for Excessive Price Hearing Recommendation.

TL

Torys LLP

The Trademark Four(Mula): Enforcement And Risk Mitigation

Trademarks are important assets for any business. When it comes to trademark enforcement, options abound, which can sometimes be disorienting for the uninitiated.

OH

Osler, Hoskin & Harcourt LLP

Q&A On Managing Intergenerational Growth In Canadian Agribusiness

Canada Real Estate

BJ

Bennett Jones LLP

July 2025 Rosen Sunshine Newsletter

Canada Government

RS

Rosen Sunshine LLP

Finalized PMPRB Guidelines Published

SB

Smart & Biggar

At Long Last: The New PMPRB Guidelines Are Here

Worldwide Healthcare

F

Fasken

CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary

Canada Healthcare

SB

Smart & Biggar

North Of Legal Or South Of Safe? Key Legal And Regulatory Considerations To Substantiate "Made In Canada" Claims

Canada Healthcare

LS

Lenczner Slaght LLP

CDA Opens Public Consultation On Pharmacare National Formulary – Deadline July 18, 2025

Canada Healthcare

F

Fasken

Health Canada's New Draft Guidance For Biosimilar Biologic Drugs

Canada Healthcare

F

Fasken

Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training

Canada Healthcare

SB

Smart & Biggar

Pharma, National Security And Tariffs: Where Do We Go From Here?

Canada Healthcare

BL

Borden Ladner Gervais LLP

CDA Opens Public Consultation On Pharmacare National Formulary – Deadline July 18, 2025

On June 19, 2025, the Essential Prescription Drugs and Related Products Advisory Panel of Canada's Drug Agency ("CDA") opened a public consultation...

Canada Healthcare

F

Fasken

Health Canada's New Draft Guidance For Biosimilar Biologic Drugs

On June 10, 2025, Health Canada issued a draft of the new "Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs...

Canada Healthcare

F

Fasken

Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training

TheraPsil, a patient advocacy organization, and 73 healthcare practitioners (HCPs) have succeeded in the Federal Court of Appeal (FCA) to overturn the refusal of the Minister of Mental Health...

Canada Healthcare

SB

Smart & Biggar

Pharma, National Security And Tariffs: Where Do We Go From Here?

After the tariff frenzy of the first quarter of this year, we've sailed into the doldrums. Not that the tariffs have gone away, or the threat of new ones has subsided, or there is a solid prospect...

Canada Healthcare

BL

Borden Ladner Gervais LLP

Psychedelic Appeal: FCA Rules That Government Must Explain Policy Change On Psilocybin Access

Canada Healthcare

TL

Torys LLP

Legal Services For Buying Or Selling A Convenience Store In Canada

The Canadian convenience store industry remains a profitable market for investors and business owners. Those small-sized retail shops loaded with everyday items, snacks, lottery tickets, and other high-turnover consumer...

Canada Commercial

Pacific Legal PC

Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials

Health Canada has released a draft version of an amended Guidance Document on biosimilar submission requirements (link here). In a significant reversal of policy...

Canada Healthcare

MT

McCarthy Tétrault LLP

Health Canada Proposes To Remove Phase III Trial Requirement From Biosimilar Approval Pathway

On June 10, 2025, Health Canada released a draft revision to its Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs, opening a consultation period that runs until September 8, 2025.

Canada Healthcare

GW

Gowling WLG

Drug And Alcohol Testing In Canada: SCC Denies Leave To Appeal In Power Workers' Union v. Canada

On May 29, 2025, the Supreme Court of Canada (SCC) dismissed an application for leave to appeal from the decision of the Federal Court of Appeal (FCA) upholding drug and alcohol testing requirements...

Canada Employment

BL

Borden Ladner Gervais LLP

Apotex Not Entitled To Damages For Delayed Generic Drug Launch

TS

Tierney Stauffer LLP

CDA Update: New Five-Year Strategic Plan And Position Statement On Using AI In Health Technology Assessments

Canada Healthcare

SB

Smart & Biggar

Sector Snapshot: Private Equity Increasingly Hungry For Food And Beverage Industry Deals

Canada Healthcare

BJ

Bennett Jones LLP

Alexion Awarded Injunction Against Amgen In SOLIRIS Patent Action; Court Considers Anticipation By Incorporation By Reference

SB

Smart & Biggar

CBSA Guidance Seeks To Narrow Scope Of Relief From Canada's Retaliatory Tariffs

Canada International

MT

McCarthy Tétrault LLP

How Do I Get Out Of This? New Guidance On Eligibility For Tariff Remissions And Support Programs For Canadian Businesses

Canada International

BJ

Bennett Jones LLP

Court Of Appeal Cuts Off Speculative Product Liability Claims

Canada Litigation

BJ

Bennett Jones LLP

Government Of Ontario Tables Budget 2025: A Plan To Protect Ontario

Worldwide Strategy

GW

Gowling WLG

Episode 76: Scaling Impact Through Entrepreneurship In Food And Hospitality (Podcast)

Canada Commercial

D

Dentons

Arbitrator Rejects "Lowest-Cost Generic" Policy For Generic Substitutes In Collective Bargaining Agreement

Canada Employment

C

Cassels

Court Finds Eculizumab Patent Neither Anticipated Nor Obvious

AK

Aitken Klee

Landlords May Soon Need To Be On (Top Of) Drugs: Unpacking Ontario's Bill 10

Canada Real Estate

RA

Robins Appleby LLP

Mandatory Front-of-package Labelling Compliance By 2026 — Are You Prepared?

Canada Healthcare

BL

Borden Ladner Gervais LLP

A Guide To Commercial Patriotism: Understanding 'Made In Canada' And Similar Labels

Canada Anti-trust

AB

Aird & Berlis LLP

5 Key Trends Shaping The Life Sciences Industry (Video)

Canada Healthcare

RS

RSM Canada

See more

Latest Videos

See more

Drug Pricing And Reimbursement: The Role Of Provinces And Hospitals In Pharmaceutical Pricing (Video)

TL

Torys LLP

Nutrition Tips & Advice During COVID-19 (Video)

GW

Gowling WLG

Le Secteur De La Santé Au Canada Après La COVID-19 : Perspectives Juridiques, Médicales Et Commerciales (vidéos)

SE

Stikeman Elliott LLP

What Are The Challenges And Opportunities In Ontario's Budding Cannabis Retail Market? (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Two: Weed Growth (Video)

D

Dentons

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More